Entero Healthcare Solutions Limited

Consumer Discretionary›Consumer Services›Retailing›Pharmacy Retail

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹1174.00
Market cap
5,108 Cr
Stock P/E
34.2
P/B
2.91

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales2,888 Cr3,922 Cr1,097 Cr2,398 Cr1,359 Cr1,339 Cr1,404 Cr1,571 Cr1,707 Cr1,910 Cr
Operating expenses (approx.)2,800 Cr3,796 Cr1,053 Cr2,300 Cr1,301 Cr1,283 Cr1,348 Cr1,504 Cr1,642 Cr1,820 Cr
EBITDA88 Cr126 Cr44 Cr97 Cr58 Cr56 Cr56 Cr67 Cr64 Cr90 Cr
OPM %3.1%3.2%4.0%4.1%4.2%4.2%4.0%4.3%3.8%4.7%
Other income5 Cr14 Cr13 Cr25 Cr7 Cr7 Cr6 Cr5 Cr5 Cr4 Cr
Interest48 Cr66 Cr10 Cr21 Cr10 Cr10 Cr11 Cr12 Cr14 Cr17 Cr
Depreciation18 Cr25 Cr7 Cr14 Cr8 Cr8 Cr9 Cr10 Cr10 Cr15 Cr
Profit before tax22 Cr36 Cr27 Cr62 Cr39 Cr37 Cr36 Cr45 Cr40 Cr58 Cr
Tax %15.3%-11.9%24.8%25.0%25.3%15.6%16.9%18.0%16.1%22.1%
Net profit19 Cr40 Cr21 Cr47 Cr29 Cr31 Cr30 Cr37 Cr34 Cr45 Cr
EPS (₹)₹5.18₹10.81₹4.62₹10.05₹5.85₹5.91₹6.39₹7.26₹6.35₹6.44

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales3,922 Cr5,096 Cr6,591 CrSign in for TTM
Operating expenses (approx.)3,810 Cr4,885 Cr6,314 CrSign in for TTM
EBITDA112 Cr211 Cr277 CrSign in for TTM
OPM %2.9%4.1%4.2%Sign in for TTM
Other income14 Cr40 Cr19 CrSign in for TTM
Interest66 Cr42 Cr54 CrSign in for TTM
Depreciation25 Cr31 Cr43 CrSign in for TTM
Profit before tax36 Cr139 Cr179 CrSign in for TTM
Tax %-11.9%22.6%18.7%Sign in for TTM
Net profit40 Cr107 Cr146 CrSign in for TTM
EPS (₹)₹10.81₹21.80₹26.44Sign in for TTM
Dividend payout %0.0%0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital43 Cr44 Cr44 Cr
Reserves1,598 Cr1,681 Cr1,645 Cr
Borrowings276 Cr299 Cr444 Cr
Other liabilities428 Cr633 Cr1,404 Cr
Total liabilities2,345 Cr2,703 Cr3,600 Cr
Fixed assets (net)93 Cr132 Cr103 Cr
CWIP—0.0000 Cr0.0000 Cr
Investments0.0000 Cr58 Cr130 Cr
Other assets2,011 Cr2,076 Cr2,503 Cr
Total assets2,345 Cr2,703 Cr3,600 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity-37 Cr-77 Cr96 Cr
Cash from investing-705 Cr220 Cr-303 Cr
Cash from financing863 Cr-74 Cr124 Cr
Net cash flow121 Cr69 Cr-83 Cr
Free cash flow (OCF − Capex)-42 Cr-88 Cr29 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2024Mar 2025Mar 2026
ROCE %4.5%8.7%10.6%
ROE %2.4%5.4%6.6%
Debtor days57——
Inventory days394746
Days payable21——
Cash conversion cycle754746
Debt / equity0.170.170.25
Current ratio3.342.461.58
Net debt / EBITDA1.140.331.07

Compare with peers

Loading peers…